Literature DB >> 2441199

Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model.

P A de Graeff, W H van Gilst, K Bel, C D de Langen, J H Kingma, H Wesseling.   

Abstract

We previously reported concentration-dependent protection of captopril against ischemia-reperfusion injury in the isolated rat heart. In order to study these effects in vivo, we developed a closed-chest pig model. Reversible occlusion of the left coronary artery was achieved with a PTCA catheter during one hour. Captopril (C) i.v. was given in two different concentrations (0.6 mg/kg/10 min + 0.3 mg/kg/2 hr and 6 mg/kg/10 min + 3.0 mg/kg/2 hr) during the experiments to 11 and 10 pigs, respectively, versus 12 controls, who received only saline. Due to malignant ventricular arrhythmias, nine pigs died during ischemia. At the end of the reperfusion period of two hours, eight pigs were alive in each group. In the C-treated pigs, maximum creatine kinase after two hours of reperfusion was significantly lowered to 6,337 +/- 709 U/L in the high dose group versus 8,285 +/- 851 U/L in the low dose group and 9,635 +/- 1,115 U/L in the saline group. A reduction of local inosine overflow in the coronary sinus was seen. Maximum noradrenaline overflow after 5 min reperfusion diminished dose-dependently to 695 +/- 284 and 3,129 +/- 1,728 pg/ml in the C treated groups versus 4,693 +/- 2,277 pg/ml in the saline group. Mean arterial blood pressure and cardiac output decreased significantly during ischemia and reperfusion, but no significant differences occurred between the treated and untreated groups. Reperfusion arrhythmias, mainly accelerated idioventricular rhythm disturbances, were comparable among the three groups. We conclude that in vivo administration of C reduces myocardial damage upon reperfusion after one hour of ischemia in a dose-dependent way.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441199     DOI: 10.1097/00005344-198700002-00009

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.

Authors:  R A Tio; C D de Langen; P A de Graeff; W H van Gilst; K J Bel; K G Wolters; P H Mook; J van Wijngaarden; H Wesseling
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.

Authors:  B Fabris; H Yamada; R Cubela; B Jackson; F A Mendelsohn; C I Johnston
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  Cardioprotective effect of orally administered angiotensin-converting enzyme inhibitor against ischemia. Reperfusion injury in the isolated rat heart.

Authors:  M Hata; A Iguchi; Y Li; S Watanabe; M Kamada; M Ohmi; K Tabayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-09

4.  Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.

Authors:  X Liu; R M Engelman; J A Rousou; G A Cordis; D K Das
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

5.  Neuroendocrine activation after acute myocardial infarction.

Authors:  H M McAlpine; J J Morton; B Leckie; A Rumley; G Gillen; H J Dargie
Journal:  Br Heart J       Date:  1988-08

6.  Beneficial effects of bradykinin on porcine ischemic myocardium.

Authors:  R A Tio; T J Tobé; K J Bel; C D de Langen; W H van Gilst; H Wesseling
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

7.  Effect of the angiotensin-converting enzyme inhibitor, perindoprilat, and of angiotensin-II on the transient inward current of rabbit ventricular myocytes.

Authors:  R Enous; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 8.  Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.

Authors:  K Przyklenk; R A Kloner
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.